Definitive Healthcare Corp(DH) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -1.61 | Insider Own | 70.56% | Shs Outstand | 106.4M | Perf Week | -0.87% |
| Market Cap | 0.17B | Forward P/E | 6.11 | EPS next Y | -4.18% | Insider Trans | - | Shs Float | 31.4M | Perf Month | 22.58% |
| Enterprise Value | 0.19B | PEG | - | EPS next Q | 0.04 | Inst Own | 22.68% | Short Float | 6.13% | Perf Quarter | 58.97% |
| Income | -0.17B | P/S | 0.71 | EPS this Y | -18.87% | Inst Trans | -1.5% | Short Ratio | 3.16 | Perf Half Y | 21.99% |
| Sales | 0.23B | P/B | 0.84 | EPS next 5Y | -8.31% | ROA | -26.55% | Short Interest | 1.93M | Perf YTD | -60.28% |
| Book/sh | 1.36 | P/C | 0.9 | EPS past 3/5Y | -163.26% -19.83% | ROE | -75.04% | 52W High | -62% ($3.00) | Perf Year | -61.22% |
| Cash/sh | 1.27 | P/FCF | 5.78 | Sales past 3/5Y | 2.75% 15.34% | ROIC | -56.01% | 52W Low | 86.79% ($0.61) | Perf 3Y | -80.81% |
| Dividend Est. | - | EV/EBITDA | 5.43 | EPS Y/Y TTM | 39.52% | Gross Margin | 60.13% | Volatility(W/M) | 6.69% 5.09% | Perf 5Y | -96.93% |
| Dividend TTM | - | EV/Sales | 0.82 | Sales Y/Y TTM | -4.99% | Oper. Margin | -8.45% | ATR (14) | 0.06 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.77 | EPS Q/Q | 27.58% | Profit Margin | -72.28% | RSI (14) | 67.85 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.77 | Sales Q/Q | -9.14% | SMA20 | 10.87% ($1.03) | Beta | 1.44 | Target Price | $1.9 |
| Payout | - | Debt/Eq | 1.15 | Earnings | 2026/8/10 | SMA50 | 18.44% ($0.96) | Rel Volume | 0.77 | Prev Close | $1.11 |
| Employees | 686 | LT Debt/Eq | 1.08 | EPS/Sales Surpr. | 17.1% -0.5% | SMA200 | 4.47% ($1.09) | Avg Volume(3M) | 0.61M | Price | $1.14 |
| IPO | 2021/9/15 | Option/Short | Yes/Yes | Trades | 1691 | Volume | 472,445 | Change | 3.17% |
🏥 Definitive Healthcare is a SaaS company that provides commercial data and intelligence across the entire U.S. healthcare industry. It has built a database of extensive healthcare provider information—including hospitals, physicians, and payers—to support the sales and market entry strategies of pharmaceutical, medical device, and healthcare companies. The company operates on a subscription-based, recurring revenue model.
Over the past 1 year, on the lower side
62% below its 1-year high.
Traded less than usual. That is 77% of its average volume.
DH has a sound balance sheet but weak earning power
Of every $100 in sales, $8.45 is lost.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -18.9% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $71. Peers typically go for $90.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -96.9%. The S&P 500 did +69% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 22.7%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #28 of 41 in the industry
Based on market cap of $165M.
SPOK#25 Spok Holdings Inc $213M PER 17.5 
SY#26 So-Young International Inc ADR $179M PER - 
OPRX#27 OptimizeRx Corp $175M PER 39.5 DH#28 Definitive Healthcare Corp $165M PER - 
HCAT#29 Health Catalyst Inc $135M PER - 
FAQ
What kind of company is DH?
DH belongs to the Healthcare sector and operates in the Health Information Services industry.
What is the market cap of DH?
The market cap of DH is approximately $165M, ranking 4,164 within its sector.
What is the 52-week high and low for DH?
DH has recorded a 52-week high of $3.00 and a low of $0.61.
